Endoscopic balloon dilation management for benign duodenal stenosis.
Balloon dilation
Duodenal stenosis
Endoscopy
Journal
Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
08
10
2022
accepted:
19
12
2022
medline:
5
5
2023
pubmed:
10
1
2023
entrez:
9
1
2023
Statut:
ppublish
Résumé
Benign duodenal stenosis (BDS) is most commonly caused by peptic ulcer disease (PUD). Endoscopic balloon dilation (EBD) is the recommended initial management despite limited supporting literature. Our study investigated the etiologic spectrum of BDS and its response to endoscopic dilation. We performed a cohort study of a prospectively maintained database of BDS at our large tertiary academic center between 2002 and 2018. All patients who underwent EBD were analyzed. Dilation was performed using through-the-scope balloons. Technical and clinical successes of initial and repeat EBD were compared. Descriptive statistics, univariate, and multivariate analysis were performed. The study included 86 patients with 54.7% female gender. Etiologies included 39 patients with PUD (45.3%), 19 patients with Crohn's disease (22.1%), 23 patients had idiopathic etiologies (26.7%), and 5 patients were listed as other etiologies (5.8%). Proximal stricture location (1st part of duodenum) occurred in 66% of females, whereas distal duodenal involvement was seen in 63.6% of males (p value 0.007). Usage of PPI was associated with 3.6 times higher clinical success rate (p value 0.04). Technical (97.4%) and clinical (77.8%) successes for index dilations in PUD were not significantly better than those of non-PUD patients (p values 0.99, 0.52). EBD has both a high technical and clinical success for BDS regardless of etiology and should be considered over initial surgical intervention due to low risk profile. Males tend to have more distal duodenal involvement, and PPI usage is an independent predictor for clinical success.
Sections du résumé
BACKGROUND AND AIMS
Benign duodenal stenosis (BDS) is most commonly caused by peptic ulcer disease (PUD). Endoscopic balloon dilation (EBD) is the recommended initial management despite limited supporting literature. Our study investigated the etiologic spectrum of BDS and its response to endoscopic dilation.
METHODS
We performed a cohort study of a prospectively maintained database of BDS at our large tertiary academic center between 2002 and 2018. All patients who underwent EBD were analyzed. Dilation was performed using through-the-scope balloons. Technical and clinical successes of initial and repeat EBD were compared. Descriptive statistics, univariate, and multivariate analysis were performed.
RESULTS
The study included 86 patients with 54.7% female gender. Etiologies included 39 patients with PUD (45.3%), 19 patients with Crohn's disease (22.1%), 23 patients had idiopathic etiologies (26.7%), and 5 patients were listed as other etiologies (5.8%). Proximal stricture location (1st part of duodenum) occurred in 66% of females, whereas distal duodenal involvement was seen in 63.6% of males (p value 0.007). Usage of PPI was associated with 3.6 times higher clinical success rate (p value 0.04). Technical (97.4%) and clinical (77.8%) successes for index dilations in PUD were not significantly better than those of non-PUD patients (p values 0.99, 0.52).
CONCLUSION
EBD has both a high technical and clinical success for BDS regardless of etiology and should be considered over initial surgical intervention due to low risk profile. Males tend to have more distal duodenal involvement, and PPI usage is an independent predictor for clinical success.
Identifiants
pubmed: 36624215
doi: 10.1007/s00464-022-09844-0
pii: 10.1007/s00464-022-09844-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3610-3618Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Sigmon DF, Eovaldi BJ, Cohen HL (2022) Duodenal atresia and stenosis. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470548/ . Accessed 29 Aug 2022
Kochhar R, Kochhar S (2010) Endoscopic balloon dilation for benign gastric outlet obstruction in adults. World J Gastrointest Endosc 2(1):29–35
doi: 10.4253/wjge.v2.i1.29
pubmed: 21160676
pmcid: 2998862
Bruno MJ, Maluf-Filho F (2019) Palliation of malignant pancreaticobiliary obstruction. In: Chandrasekhar V et al (eds) Clinical gastrointestinal endoscopy, 3rd edn. Elsevier, Philadelphia, PA, pp 734–747
Mangiavillano B, Khashab MA, Tarantino I et al (2019) Success and safety of endoscopic treatments for concomitant biliary and duodenal malignant stenosis: A review of the literature. World J Gastrointest Surg 11(2):53–61
doi: 10.4240/wjgs.v11.i2.53
pubmed: 30842812
pmcid: 6397798
Shone DN, Nikoomanesh P, Smith-Meek MM, Bender JS (1995) Malignancy is the most common cause of gastric outlet obstruction in the era of H2 blockers. Am J Gastroenterol 90(10):1769–1770
pubmed: 7572891
Kozoll DD, Meyer KA (1964) Obsturcting Gastroduodenal Ulcer. Symptoms and Signs Arch Surg 89:491–498
doi: 10.1001/archsurg.1964.01320030081014
pubmed: 14167403
Jaffin BW, Kaye MD (1985) The prognosis of gastric outlet obstruction. Ann Surg 201(2):176–179
doi: 10.1097/00000658-198502000-00007
pubmed: 3970597
pmcid: 1250637
Weiland D, Dunn DH, Humphrey EW, Schwartz ML (1982) Gastric outlet obstruction in peptic ulcer disease: an indication for surgery. Am J Surg 143:90–93
doi: 10.1016/0002-9610(82)90135-0
pubmed: 7053661
Chaudhary A, Puri AS, Dhar P, Reddy P, Sachdev A, Lahoti D, Kumar N, Broor SL (1996) Elective surgery for corrosive induced gastric injury. World J Surg 20:703–706; discussion 706
Yusuf TE, Brugge WR (2006) Endoscopic therapy of benign pyloric stenosis and gastric outlet obstruction. Curr Opin Gastroenterol 22:570–573
doi: 10.1097/01.mog.0000239874.13867.41
pubmed: 16891891
Cherian PT, Cherian S, Singh P (2007) Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy. Gastrointest Endosc 66(3):491–497
doi: 10.1016/j.gie.2006.11.016
pubmed: 17640640
Kochhar R, Sethy PK, Nagi B et al (2004) Endoscopic balloon dilatation of benign gastric outlet obstruction. J Gastroenterol Hepatol 19:418–422
doi: 10.1111/j.1440-1746.2003.03283.x
pubmed: 15012779
Hamzaoui L, Bouassida M, Ben Mansour I et al (2015) Balloon dilatation in patients with gastric outlet obstruction related to peptic ulcer disease. Arab J Gastroenterol 16(3–4):121–124
doi: 10.1016/j.ajg.2015.07.004
pubmed: 26440958
Kochhar R, Malik S, Gupta P et al (2018) Etiological spectrum and response to endoscopic balloon dilation in patients with benign gastric outlet obstruction. Gastrointest Endosc 88(6):899–908
doi: 10.1016/j.gie.2018.06.037
pubmed: 30017869
Rana SS, Bhasin DK, Chandail VS et al (2011) Endoscopic balloon dilatation without fluoroscopy for treating gastric outlet obstruction because of benign etiologies. Surg Endosc 25:1579–1584
doi: 10.1007/s00464-010-1442-y
pubmed: 21052720
Maharshi S, Puri AS, Sachdeva S et al (2016) Aetiological spectrum of benign gastric outlet obstruction in India: new trends. Trop Doct 46:186–191
doi: 10.1177/0049475515626032
pubmed: 26774109
Fallone CA, Chiba N, van Zanten SV et al (2016) The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology 151(1):51–69
doi: 10.1053/j.gastro.2016.04.006
pubmed: 27102658
Boylan JJ, Gradzka MI (1999) Long-term results of endoscopic balloon dilatation for gastric outlet obstruction. Dig Dis Sci 44:1883–1886
doi: 10.1023/A:1018807125952
pubmed: 10505729
Solt J, Bajor J, Szabo M et al (2003) Long-term results of balloon catheter dilation for benign gastric outlet stenosis. Endoscopy 35:490–495
doi: 10.1055/s-2003-39664
pubmed: 12783346
Feldman M, Friedman LS, Brandt LJ (2016) Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology/diagnosis/management, vol 2, 10th edn. Saunders/Elsevier, Philadelphia, PA (p xxxi, 2369, 2389)
Fortun PJ, Hawkey CJ (2007) Nonsteroidal antiinflammatory drugs and the small intestine. Curr Opin Gastroenterol 23(2):134–141
pubmed: 17268241
Gajendran M, Loganathan P, Catinella AP, Hashash JG (2018) A comprehensive review and update on Crohn’s disease. Dis Mon 64(2):20–57
doi: 10.1016/j.disamonth.2017.07.001
pubmed: 28826742
Bessissow T, Reinglas J, Aruljothy A, Lakatos PL, Van Assche G (2018) Endoscopic management of Crohn’s strictures. World J Gastroenterol 24(17):1859–1867
doi: 10.3748/wjg.v24.i17.1859
pubmed: 29740201
pmcid: 5937203
Williams AJ, Palmer KR (1991) Endoscopic balloon dilatation as a therapeutic option in the management of intestinal strictures resulting from Crohn’s disease. Br J Surg 78(4):453–454
doi: 10.1002/bjs.1800780421
pubmed: 2032105